CC
IRWD icon

Centiva Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Centiva Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,092
Closed -$198K – 1495
2022
Q3 		$198K Buy
+19,092
New +$216K ﹤0.01% 1181
2021
Q4 		– Sell
-15,787
Closed -$206K – 1363
2021
Q3 		$206K Sell
15,787
-2,110
-12% -$27.3K 0.01% 917
2021
Q2 		$230K Buy
+17,897
New +$205K 0.01% 1158

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Centiva Capital's IRWD Position: Q4 2022 in Review

Centiva Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2022, closing a stake of 19,092 shares — an estimated $198K sold.

Centiva Capital first reported a position in IRWD in Q2 2021 and held it in 3 quarters. The position peaked at $230K in Q2 2021. 249 funds tracked by Wall St. Rank hold IRWD as of Q4 2022.

  • Centiva Capital reported no remaining Ironwood Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Centiva Capital sold 19,092 Ironwood Pharmaceuticals shares in Q4 2022, an estimated $198K.
  • Centiva Capital first reported a position in Ironwood Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • Centiva Capital's Ironwood Pharmaceuticals position peaked at $230K in Q2 2021.
  • 249 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2022.

Based on Centiva Capital's 13F filing for Q4 2022, filed 14 Feb 2023.